title: Lasiodiplodan, an exocellular (1→6)-β-D: -glucan from Lasiodiplodia theobromae MMPI: production on glucose, fermentation kinetics, rheology and anti-proliferative activity.
abstract: Lasiodiplodan, an exopolysaccharide of the (1→6)-β-D: -glucan type, is produced by Lasiodiplodia theobromae MMPI when grown under submerged culture on glucose. The objective of this study was to evaluate lasiodiplodan production by examining the effects of carbon (glucose, fructose, maltose, sucrose) and nitrogen sources (KNO(3), (NH(4))(2)SO(4), urea, yeast extract, peptone), its production in shake flasks compared to a stirred-tank bioreactor, and to study the rheology of lasiodiplodan, and lasiodiplodan's anti-proliferative effect on breast cancer MCF-7 cells. Although glucose (2.05 ± 0.05 g L(-1)), maltose (2.08 ± 0.04 g L(-1)) and yeast extract (2.46 ± 0.06 g L(-1)) produced the highest amounts of lasiodiplodan, urea as N source resulted in more lasiodiplodan per unit biomass than yeast extract (0.74 ± 0.006 vs. 0.22 ± 0.008 g g(-1)). A comparison of the fermentative parameters of L. theobromae MMPI in shake flasks and a stirred-tank bioreactor at 120 h on glucose as carbon source showed maximum lasiodiplodan production in agitated flasks (7.01 ± 0.07 g L(-1)) with a specific yield of 0.25 ± 0.57 g g(-1) and a volumetric productivity of 0.06 ± 0.001 g L(-1) h(-1). A factorial 2(2) statistical design developed to evaluate the effect of glucose concentration (20-60 g L(-1)) and impeller speed (100-200 rpm) on lasiodiplodan production in the bioreactor showed the highest production (6.32 g L(-1)) at 72 h. Lasiodiplodan presented pseudoplastic behaviour, and the apparent viscosity increased at 60°C in the presence of CaCl(2). Anti-proliferative activity of lasiodiplodan was demonstrated in MCF-7 cells, which was time- and dose-dependent with an IC(50) of 100 μg lasiodiplodan mL(-1).
authors.affiliation: Department of Chemistry, Federal Technological University of Paraná, Pato Branco, PR, Brazil. mcunha@utfpr.edu.br
authors.forename: Mário A
authors.initials: MA
authors.lastname: Alves da Cunha
authors.forename: Janaína A
authors.initials: JA
authors.lastname: Turmina
authors.forename: Raphael C
authors.initials: RC
authors.lastname: Ivanov
authors.forename: Roney R
authors.initials: RR
authors.lastname: Barroso
authors.forename: Patrícia T
authors.initials: PT
authors.lastname: Marques
authors.forename: Eveline A I
authors.initials: EA
authors.lastname: Fonseca
authors.forename: Zuleica B
authors.initials: ZB
authors.lastname: Fortes
authors.forename: Robert F H
authors.initials: RF
authors.lastname: Dekker
authors.forename: Neelam
authors.initials: N
authors.lastname: Khaper
authors.forename: Aneli M
authors.initials: AM
authors.lastname: Barbosa
mesh_terms: D001203:Ascomycota / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D018533:Biomass; D019149:Bioreactors; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology*; D049109:Cell Proliferation / Q000187:drug effects; D005285:Fermentation / Q000187:drug effects; D005936:Glucans / Q000096:biosynthesis* / Q000737:chemistry* / Q000378:metabolism; D005947:Glucose / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D061986:MCF-7 Cells; D008320:Maltose / Q000378:metabolism / Q000494:pharmacology; D009584:Nitrogen / Q000378:metabolism; D012212:Rheology; D013395:Sucrose / Q000378:metabolism / Q000494:pharmacology
chemical_list: D005936:Glucans; D013395:Sucrose; D008320:Maltose; D005947:Glucose; D009584:Nitrogen